Location History:
- The Oxford Science Park, GB (2004)
- Oxford, GB (2014)
Company Filing History:
Years Active: 2004-2014
Title: Innovations by Inventor Stuart Naylor in Immunotherapy
Introduction
Stuart Naylor, a distinguished inventor based in Oxford, GB, has made significant contributions to the field of immunotherapy. With a remarkable portfolio of two patents, his work primarily focuses on advanced methods for treating neurodegenerative diseases and monitoring the efficacy of immunotherapies.
Latest Patents
Naylor’s latest innovations include an "Immunotherapeutic method" that offers a novel approach to track the effectiveness of immunotherapies in mammalian subjects. This method utilizes a viral vector containing a polynucleotide coding for an antigen, enabling targeted transduction of cells to induce antigen expression. Additionally, his patent on "Lentiviral-mediated growth factor gene therapy for neurodegenerative diseases" describes advanced techniques for treating conditions like Parkinson's disease. This method incorporates a lentiviral vector that expresses GDNF (glial cell-derived neurotrophic factor), aimed at not only treating but also regenerating nigrostriatal pathways, thereby addressing symptoms and physiology linked with these debilitating conditions.
Career Highlights
Throughout his professional journey, Stuart Naylor has held positions at prestigious companies such as Oxford Biomedica Limited and Oxford Biomedica, Inc. These experiences have paved the way for his innovative research and development efforts in the field of biotechnology and gene therapy.
Collaborations
Naylor has collaborated with prominent figures in the research community, including Patrick Aebischer and Susan Mary Kingsman. Their collective expertise has contributed to the advancement of innovative therapeutic methods that strive to combat significant health challenges.
Conclusion
Stuart Naylor's work represents the forefront of innovation in immunotherapy and neurodegenerative disease treatment. His patents not only highlight his dedication to improving patient outcomes but also underscore the importance of collaborative efforts in the scientific community. As advancements in technology continue to evolve, Naylor's contributions will undoubtedly play a crucial role in shaping future therapeutic approaches.